Media Centre
The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent agency funded by Canadian federal, provincial, and territorial governments to provide health care decision makers with credible, impartial advice and information about the effectiveness and efficiency of drugs and other health technologies. Unlike regulators who determine which technologies can be used in Canada, CADTH supports decision makers who are exploring what technologies should be used to achieve the best outcomes both on patient health and the health care system.
CADTH Publishes Oncology Guidelines
December 21, 2009
CADTH is proud to announce the publication on our website of the "Guidelines for the Economic Evaluation of Health Technologies: Specific Guidance for Oncology Products.”
These guidelines are intended to provide specific guidance on the methods used to conduct high-quality economic evaluations of oncology products, and should be considered a companion document to CADTH’s Guidelines for the Economic Evaluation of Health Technologies (3rd Edition).
CADTH collaborated with the Working Group on Economic Analysis from the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG).